Investigation of Body Fluids Intervention Impact on Aptamer Screening via Capillary Electrophoresis
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.5c00369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Chao Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, 5 South Zhongguancun Street, Beijing 10…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, SELEX Aptamer Technique, Body Fluids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Shandong Academy of Agricultural Sciences, Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aptamers have presented considerable potential for disease diagnoses but still face a great challenge from the discrepancy between their screening conditions and real application in body fluid matrices (BFMs). In this study, we investigated the impact of BFM intervention on aptamer screening based on CE efficient separation and introduced adaptive screening strategies directly under the BFM background. Five BFMs, including serum, tears, artificial cerebrospinal fluid, saliva, and embryonic fluid, demonstrated the potential differentiating effects on aptamer screening based on the characterization of their "fingerprint-like profile" and their interactions with ssDNA libraries. Besides, the matrix effects of the five BFMs were quantified by calculating kinetic parameters derived from binding investigations between disease marker protein-spiked BFMs and ssDNA libraries. Through quantitative evaluation, two tailored SELEX strategies were introduced in BFM-intervened aptamer screening: spiking foreign proteins to the BFMs, and targeting proteins naturally abundant in BFMs. As proof of concept, we completed aptamer screenings for prolactin-induced protein (serum, spiked target) and human lactoferrin (tears, natural target) via CE-SELEX that demonstrated its adaptability in "splitting" BFM interference and achieving a clear collection of target-ssDNA complex. This study highlighted the critical importance of incorporating BFMs into SELEX and provided two tailored strategies that are worthy of choice for effective aptamer discovery, advancing the practical utility of aptamers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, 5 South Zhongguancun Street, Beijing 100081, China.
- Institute of Quality Standard and Testing Technology for Agro-Products, Shandong Academy of Agricultural Sciences, Jinan 250100, China.
- CAMS Key Laboratory of Antiviral Drug Research, Beijing Key Laboratory of Antimicrobial Agents, NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Scienc…
- Precision and Intelligence Medical Imaging Lab, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
ORCID-Profile: Feng Qu
Förderung
- Shandong Academy of Agricultural Sciences
- Taishan Scholar Project of Shandong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhu, C., Chen, L., Wei, B., Yang, G., Zhao, L., & Qu, F. (2025). Investigation of Body Fluids Intervention Impact on Aptamer Screening via Capillary Electrophoresis. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c00369
Vancouver
Zhu C, Chen L, Wei B, Yang G, Zhao L, Qu F. Investigation of Body Fluids Intervention Impact on Aptamer Screening via Capillary Electrophoresis. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c00369
BibTeX
@article{Zhu2025,
author = {Zhu, Chao and Chen, Li and Wei, Bo and Yang, Ge and Zhao, Liping and Qu, Feng},
title = {Investigation of Body Fluids Intervention Impact on Aptamer Screening via Capillary Electrophoresis},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.5c00369}
}
EUVIMED